Navigation Links
Educating Key Stakeholder to Support a Successful Diabetes Product Launch
Date:7/19/2013

CHAPEL HILL, N.C., July 19, 2013 /PRNewswire/ -- The bio-pharmaceutical marketplace – and the diabetes therapeutic area in particular – continues to evolve as new medicines and technologies create valuable market opportunities. It's in this competitive and challenging environment that organizations with new Diabetes products are scrutinizing their strategies and tactics to support market education.

When it comes to timing medical education efforts directed at healthcare providers, Diabetes teams follow the Specialist to Primary Care Physician to Nurse Practitioner cascade. However, they introduce targeting to Primary Care Physicians and Nurse Practitioners somewhat earlier – at two year pre-launch – than other therapeutic areas, according to new research from Best Practices, LLC. This likely reflects the importance of PCPs and Nurses in diabetes treatment.

The report, Shaping the Marketplace to Support Successful Diabetes Product Launches: Tactics for Educating KOLs, Physicians, Patients and Payers, contains a plethora of benchmark metrics on the most effective physician, payer and patient education practices conducted from clinical development through launch. The 160-page report contains almost 500 metrics to help inform launch leaders in the Diabetes area on the most effective type and timing of market education practices during the full development cycle.

The research - which includes Diabetes and total benchmark class segments - attracted 34 executives and managers from 26 leading pharmaceutical, biotech and medical device companies, including 13 of the Top 20 pharmaceutical companies. Additionally, the research reflects on nine deep-dive interviews with selected participants.

Key Topics of this report include:

  • Identification of Key Education Tactics for Thought Leaders, Phy
    '/>"/>

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints
2. Educating, Informing, and Successfully Preparing the Marketplace for New Bio-Pharma Products
3. Society for Clinical Research Sites Receives Unprecedented Response from Industry Stakeholders to Support Sites by Joining Corporate Partnership Program
4. Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness
5. National Pharmaceutical Council Survey Shows Health Care Stakeholders Continue to Show Optimism About the Future Role of Comparative Effectiveness Research
6. Patient Safety, Science and Technology Summit Inspires Healthcare Industry Stakeholders to Action in Pursuit of 0 Preventable Patient Deaths by 2020
7. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
8. National Stakeholders Meet To Consider Improvements In Antimicrobial Use In Food Animal Production
9. Permobil Becomes Premiere-Level Partner of The ALS Association; Will Offer Support for People Affected by Lou Gehrigs Disease
10. ViaCyte, Inc. raises $10.6 Million in a Private Financing to Support Clinical Development of its Cell Therapy Product for Insulin Dependent Diabetes
11. AdvaMed Supports Comprehensive Tax Reform Repeal of the Medical Device Tax Important First Step
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 Research and Markets ( ... "Prescription Pain Drugs - Including Opioid, Anticonvulsant, ... Markets, Competitors and Opportunities: 2015 - 2020 Analysis ... Pain is defined as an unpleasant ... potential tissue damage. At some point, everyone experiences ...
(Date:8/29/2015)... y LONDRES, August 29, 2015 ... para los sistemas de imagen por Ultrasonidos ... Ecografía, tiempos de examen rápidos y un flujo de ... confianza diagnóstica en el proceso de detección de Cardiopatías ... PHIA) ha anunciado hoy el lanzamiento europeo de ...
(Date:8/28/2015)... Calif. , Aug. 28, 2015  CytomX Therapeutics, ... treatment of cancer, today announced the filing of a ... and Exchange Commission (SEC) relating to a proposed initial ... shares to be offered and the price range for ... to list its common stock under the symbol "CTMX" ...
Breaking Medicine Technology:Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5CytomX Files Registration Statement for Proposed Initial Public Offering 2
... Dec. 4 Long-term data published in,EuroIntervention showed ... (MVA),after repair with the MitraClip(R) system to correct ... mitral stenosis. Additionally,with two years of follow-up, none ... surgery for mitral stenosis. At 12 months no,important ...
... newly diagnosed patients with a life-threatening type of leukemia to be ... , - Exjade results at ASH to show benefits ... damage key organs , , - ... to report on optimal post-surgery treatment strategy, Femara vs. tamoxifen , ...
Cached Medicine Technology:Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 2Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 3Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22
(Date:8/31/2015)... ... 31, 2015 , ... The Foundation for Women’s Cancer ... about the role of heredity in below-the-belt gynecologic cancers. , Considerable media ... Pitt’s decisions to have both her breasts and ovaries removed to prevent breast ...
(Date:8/31/2015)... ... August 31, 2015 , ... Move over shave cream. Roll over beard ... are scrambling to meet it. , Reports published this year (Mintel data) announced that ... the data also reflects that men are getting more done at barbershops than a ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... MeYou ... recently enhanced its mobile walking app, Walkadoo , by including an in-app step ... goals that adapt to each person’s walking habits. Rather than broadly assign every Walkadoo ...
(Date:8/31/2015)... ... 2015 , ... Juvent Sports ( http://www.juvent.com ) just announced the addition of ... finding joint pain relief after using their revolutionary Micro-Impact Platform™ . Wilander, winner ... said, “For the first time in over 20 years I am joint pain free. ...
(Date:8/31/2015)... , ... August 31, 2015 , ... According to book ... Solution: Taking Charge of Your Life with Cancer is an excellent resource for ... found The Cancer Solution to be helpful in explaining what cancer is in a ...
Breaking Medicine News(10 mins):Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 2Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3Health News:New Book The Cancer Solution Is a Must Read for Everyone Affected by Cancer 2
... Worksite wellness programs are a proven strategy ... disease, according to a policy statement published today ... Association . These risk factors include smoking, overweight, ... , To view the Multimedia News Release, go ...
... Information Services, a national provider of full-service medical transcription ... Chief Executive Officer. Previously Chief Operating Officer and Chief ... position immediately. , Himes will be taking over for ... new position with Reichert, Inc. Reichert is owned by ...
... health cuts medical costs and ups productivity, heart experts ... wellness programs are an effective way to reduce major ... high blood pressure and diabetes, says a new American ... disease costs the United States about $304.6 billion, the ...
... YORK (Sept. 30, 2009) -- New research by Weill ... parents and peers influence teenagers to smoke, drink and ... smoking influenced teenagers, use of multiple drugs (smoking, drinking ... boys and girls. For girls, friends were shown ...
... People who suffer from debilitating neuropathic pain may ... commonly-prescribed drugs. A new, federally-funded study by ... together is a more effective treatment than taking either ... drug (gabapentin) and an antidepressant (nortriptyline), patients suffering from ...
... system made of billions of neurons and thousands of ... of the strongest emotions, fear. Most neurological fear studies ... Missouri researchers have started using computational models of the ... Guoshi Li, an electrical and computer engineering doctoral student, ...
Cached Medicine News:Health News:Video: Worksite Wellness Programs Lower Healthcare Costs, Make Employees Healthier 2Health News:Video: Worksite Wellness Programs Lower Healthcare Costs, Make Employees Healthier 3Health News:Video: Worksite Wellness Programs Lower Healthcare Costs, Make Employees Healthier 4Health News:Heartland Information Services Appoints New Chief Executive Officer 2Health News:Workplace Wellness Seems to Really Work 2Health News:Teen attitudes toward smoking linked to likelihood of drinking and using drugs 2Health News:Chronic pain treatments work better together, says anesthesiologist 2Health News:Researchers use computational models to study fear 2
... Codman ICP Monitoring System ... of intracranial pressure at ... intraventricular levels. The information ... than through a hydrostatic ...
Slightly curved blunt dissector, double-ended. Length 11 1/2" (272 mm)...
Penfield Dissector #1...
Raney scalp clip system includes Raney scalp clips made of metal and plastic with atraumatic design. The plastic clips are disposable while the metal clips are reusable....
Medicine Products: